EarningsQ3 2025 Earnings Report

Astellas Pharma (4503N) Q3 2025 Earnings Report

1 Followers

MX:4503N Q3 2025 EPS Results

Actual EPS$6.50

Consensus EPS$5.33

Beat/MissBeat by +$1.17

One Year Ago EPS-$6.33

Actual Revenue$66.26B

Expected Revenue$61.47B

Beat/MissBeat by +$4.79B

YoY Revenue Growth+10.40%

QuarterQ3 2025

Date02/04/2026

TimeBefore Open

Conference CallWednesday, February 4, 2026

MX:4503N Upcoming Earnings

Astellas Pharma's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

MX:4503N Q3 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q2)	7.33 / -	5.13	―
Aug 05, 2026	2026 (Q1)	6.28 / 9.18	4.434	107.09% (+4.75)
Apr 27, 2026	2025 (Q4)	3.55 / 2.82	4.854	-41.95% (-2.04)
Feb 04, 2026	2025 (Q3)	5.33 / 6.50	-6.328	202.73% (+12.83)
Oct 30, 2025	2025 (Q2)	3.46 / 5.13	2.327	120.44% (+2.80)
Jul 30, 2025	2025 (Q1)	2.31 / 4.43	2.436	82.00% (+2.00)
Apr 25, 2025	2024 (Q4)	2.47 / 4.85	-2.152	325.50% (+7.01)
Feb 04, 2025	2024 (Q3)	2.85 / -6.33	1.206	-624.52% (-7.53)
Oct 30, 2024	2024 (Q2)	2.09 / 2.33	-0.093	2607.50% (+2.42)
Aug 01, 2024	2024 (Q1)	1.11 / 2.44	2.141	13.76% (+0.29)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed